US Medicare Agency Alters Payments For Use Of Telehealth Tech, Lab Specimen Collection For COVID-19
An interim final rule posted by the CMS this week widens further a series of telehealth exemptions and lab specimen collection payment provisions it has previously issued to help providers during the COVID-19 pandemic.
You may also be interested in...
A $5bn emergency fund reimbursing US clinical laboratories for scaling up COVID-19 testing with lab-developed tests must be part of a $1tn Senate coronavirus aid and relief package, clinical lab group ACLA says. Other provisions already included in the draft bill address stockpiling of testing swabs, liability protection for medtech firms, a requirement for device makers to report supply chain shortages, the expanded use of telehealth, and preventing durable medical equipment payment reductions.
In a change likely to expand use of telemedicine, clinicians will be reimbursed for remote conversations and services to Medicare beneficiaries for the duration of the COVID-19 outbreak, CMS administrator Seema Verma said on 17 March.
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.